MyeloRx,
LLC is a privately held Northern California-based biotechnology company that
develops drugs for oncology and immune-related diseases based on the natural
product triptolide. Importantly, triptolide and the plant from which it is
extracted, Tripterygium Wilfordii Hook f, has been shown to be clinically active in acute leukemias as well as in immune-based
diseases such as rheumatoid arthritis. MyeloRx has in-licensed a series of
composition of matter patents covering proprietary analogs of the natural product.
MyeloRx is a limited liability company registered in California. It was formed in 2007.The management team has extensive experience in the pharmaceutical and biotechnology field at both small and large companies.